Effect of Ayurvedic therapy on Gall bladder cancer patients.

Role of Ayurvedic medicines on carcinoma Gall bladder after conventional anti cancer therapy : A Randomised control trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023912

Enrollment

Registered

2020-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K828- Other specified diseases of gallbladder

Interventions

Intervention1: Group B: 1-BRUHAT LOKANATH RAS Dose - 250mg twice a day with Honey. Duration - 2 Months. Mode of admistration- Oral 2-MAHASHANKHVATI Dose - 250 mg twice a day with water after meals

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with clinical features of Carcinoma gallbladder in biopsy/CECT Abdomen. Patients willing to sign the consent forms.

Exclusion criteria

Exclusion criteria: Patients suffering from major systemic illness like diabetes, liver cirrhosis, MI, IHD, hypertension and pulmonary TB etc.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of ayurvedic medicine on associated signs and symptoms of carcinoma Gall bladder following conventional anti-cancer therapy.Timepoint: 2 months	—

Secondary

Measure	Time frame
To evaluate the QOL of the studied patient of carcinoma gall bladder following conventional anti-cancer therapy.Timepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Priyanka katru

National Institute of Ayurveda

portesmdr@gmail.com8764038642

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026